Ulf Bredberg

AstraZeneca (Sweden)

Papers

1

Total Citations

219

H-Index

1

About

Ulf Bredberg is a distinguished pharmaceutical scientist whose research has significantly advanced the understanding of drug metabolism and pharmacokinetics, particularly in the context of drug discovery and development. His seminal work, "Metabolic Stability for Drug Discovery and Development" (2003), with over 219 citations, remains a cornerstone reference for optimizing drug candidates by predicting their metabolic fate. Bredberg’s contributions have helped shape strategies for improving drug bioavailability and reducing toxicity, directly impacting the efficiency of early-stage pharmaceutical research. His expertise spans the integration of in vitro and in vivo data to guide lead optimization, making him a key figure in bridging preclinical science and clinical application. Beyond his highly cited paper, Bredberg’s research has influenced how metabolic stability is assessed in drug design, earning him recognition as a thought leader in the field. For students and researchers, his work exemplifies the critical role of metabolism in turning promising compounds into safe, effective therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
219
Total Citations
219
Avg Citations/Paper
🏆 Most Cited Paper
Metabolic Stability for Drug Discovery and Development
219 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: AstraZeneca (Sweden)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago